Claudia Isabel Garcia-Berumen
Overview
Explore the profile of Claudia Isabel Garcia-Berumen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torres-Isidro O, Gonzalez-Montoya M, Vargas-Vargas M, Florian-Rodriguez U, Garcia-Berumen C, Montoya-Perez R, et al.
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40006059
Aging is a process characterized by tissue degeneration, increased susceptibility to chronic degenerative diseases, infections, and the appearance of neoplasms, which leads to disability and a reduction in the length...
2.
Gonzalez-Montoya M, Vargas-Vargas M, Torres-Isidro O, Garcia-Berumen C, Cuiniche-Mendez M, Saavedra-Molina A, et al.
Metabolites
. 2024 Aug;
14(8).
PMID: 39195527
High-fat and high-carbohydrate (HF-HC) diets induce metabolic syndrome via mitochondrial dysfunction and oxidative stress. We have previously shown that this may be prevented by avocado oil, a source of bioactive...
3.
Vargas-Vargas M, Gonzalez-Montoya M, Torres-Isidro O, Garcia-Berumen C, Ortiz-Avila O, Calderon-Cortes E, et al.
World J Clin Pediatr
. 2024 Jul;
13(2):91478.
PMID: 38947987
High-saturated fat (HF) or high-fructose (HFr) consumption in children predispose them to metabolic syndrome (MetS). In rodent models of MetS, diets containing individually HF or HFr lead to a variable...
4.
Garcia-Berumen C, Vargas-Vargas M, Ortiz-Avila O, Pina-Zentella R, Ramos-Gomez M, Figueroa-Garcia M, et al.
Front Pharmacol
. 2023 Jan;
13:1089130.
PMID: 36601051
Non-alcoholic fatty liver disease (NAFLD) is characterized by lipid accumulation in hepatocytes, and in advanced stages, by inflammation and fibrosis. Excessive ROS production due to mitochondrial dysfunction contributes to NAFLD...
5.
Marquez-Ramirez C, Olmos-Orizaba B, Garcia-Berumen C, Calderon-Cortes E, Montoya-Perez R, Saavedra-Molina A, et al.
Life (Basel)
. 2021 Nov;
11(11).
PMID: 34832999
Hypertension impairs the function of the kidney and its vasculature. Adrenergic activation is involved in these processes by promoting oxidative stress and mitochondrial dysfunction. Thus, the targeting of mitochondrial function...
6.
Garcia-Berumen C, Ortiz-Avila O, Vargas-Vargas M, Del Rosario-Tamayo B, Guajardo-Lopez C, Saavedra-Molina A, et al.
Lipids Health Dis
. 2019 Apr;
18(1):78.
PMID: 30927921
Background: High fat or fructose induces non-alcoholic fatty liver disease (NAFLD) accompanied of mitochondrial dysfunction and oxidative stress. Controversy remains about whether fructose or fat is more deleterious for NAFLD...
7.
Ortiz-Avila O, Figueroa-Garcia M, Garcia-Berumen C, Calderon-Cortes E, Mejia-Barajas J, Rodriguez-Orozco A, et al.
J Bioenerg Biomembr
. 2017 Feb;
49(2):205-214.
PMID: 28214972
Hyperglycemia and mitochondrial ROS overproduction have been identified as key factors involved in the development of diabetic nephropathy. This has encouraged the search for strategies decreasing glucose levels and long-term...